TLRY
Tilray Inc
NASDAQ: TLRY · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$6.24
+1.63% today
Updated 2026-04-30
Market cap
$784.60M
P/E ratio
—
P/S ratio
0.91x
EPS (TTM)
$-14.63
Dividend yield
—
52W range
$4 – $23
Volume
4.5M
Tilray Inc (TLRY) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $443703.00 | $6.47M | $15.17M | $28.63M | $179.30M | $405.33M | $619.67M | $792.12M | $844.72M | $1.07B | $1.13B |
| Revenue growth (YoY) | — | — | — | — | +1357.4% | +134.6% | +88.7% | +526.3% | +126.1% | +52.9% | +27.8% | +6.6% | +27.3% | +4.8% |
| Cost of revenue | — | — | — | $-195866.00 | $1.88M | $2.33M | $-3.08M | $135.79M | $309.27M | $470.90M | $644.86M | $646.77M | $770.66M | $796.88M |
| Gross profit | — | — | — | $639569.00 | $4.58M | $12.84M | $31.71M | $43.51M | $96.05M | $148.77M | $147.26M | $197.95M | $304.33M | $330.11M |
| Gross margin | — | — | — | 144.1% | 70.9% | 84.6% | 110.8% | 24.3% | 23.7% | 24.0% | 18.6% | 23.4% | 28.3% | 29.3% |
| R&D | — | — | — | $55945.00 | $168990.00 | $365207.00 | $380000.00 | $1.05M | $1.92M | $1.00M | $1.91M | $918635.00 | $865231.00 | $389701.00 |
| SG&A | $98510.00 | $45337.00 | $45337.00 | $5.33M | $2.21M | $5.25M | $24.64M | $75.84M | $95.62M | $134.75M | $167.51M | $222.53M | $233.76M | $228.33M |
| Operating income | $-98510.00 | $-45337.00 | $-45337.00 | $-2.73M | $-836229.00 | $-1.03M | $-9.64M | $-138.93M | $-104.01M | $-159.63M | $-769.46M | $-1.84B | $-238.10M | $-3.13B |
| Operating margin | — | — | — | -615.8% | -12.9% | -6.8% | -33.7% | -77.5% | -25.7% | -25.8% | -97.1% | -218.4% | -22.1% | -277.9% |
| EBITDA | $-98510.00 | $-45337.00 | $-1.43M | $-5.06M | $115114.00 | $4.94M | $34.03M | $-15.05M | $-47.87M | $-297.41M | $-310.61M | $-1.72B | $-99.25M | $-2.92B |
| EBITDA margin | — | — | — | -1141.2% | 1.8% | 32.6% | 118.9% | -8.4% | -11.8% | -48.0% | -39.2% | -203.1% | -9.2% | -259.0% |
| EBIT | $-98510.00 | $-45337.00 | $-45337.00 | $-5.37M | $-614938.00 | $3.50M | $28.85M | $-32.26M | $-83.54M | $-379.33M | $-505.49M | $-1.89B | $-272.18M | $-3.10B |
| Interest expense | $2082.00 | $3348.00 | $3348.00 | $104789.00 | $215828.00 | $287266.00 | $1.05M | $5.88M | $25.64M | $37.32M | $50.02M | $62.79M | $67.13M | $56.71M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-96428.00 | $-41989.00 | $-41989.00 | $-5.27M | $305123.00 | $3.12M | $22.84M | $-25.04M | $-102.54M | $-443.75M | $-601.05M | $-1.96B | $-333.80M | $-3.00B |
| Net income growth (YoY) | — | +56.5% | +0.0% | -12439.3% | +105.8% | +921.3% | +632.9% | -209.6% | -309.6% | -332.8% | -35.4% | -225.5% | +82.9% | -798.9% |
| Profit margin | — | — | — | -1186.6% | 4.7% | 20.5% | 79.8% | -14.0% | -25.3% | -71.6% | -75.9% | -231.6% | -31.1% | -266.3% |